vs
Cellectis S.A.（CLLS）与INTELLIGENT PROTECTION MANAGEMENT CORP.（IPM）财务数据对比。点击上方公司名可切换其他公司
Cellectis S.A.的季度营收约是INTELLIGENT PROTECTION MANAGEMENT CORP.的1.5倍（$9.5M vs $6.1M），INTELLIGENT PROTECTION MANAGEMENT CORP.同比增速更快（2091.6% vs 375.0%）
Cellectis S.A.是一家法国生物制药公司，专注于开发用于癌症免疫治疗的基因编辑嵌合抗原受体T细胞技术，目前在巴黎、纽约以及北卡罗来纳州罗利均设有办公机构，在肿瘤免疫基因编辑疗法领域拥有多年研发积累。
智能防护管理公司是一家总部位于英国格洛斯特郡的控股母公司，于2008年5月21日完成注册。公司为旗下四家子公司提供集团管理架构，其前身是专精于情报搜集、反间谍与反窃听检测业务的国际情报有限公司。
CLLS vs IPM — 直观对比
营收规模更大
CLLS
是对方的1.5倍
$6.1M
营收增速更快
IPM
高出1716.6%
375.0%
损益表 — Q2 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.5M | $6.1M |
| 净利润 | $-25.3M | — |
| 毛利率 | — | 53.1% |
| 营业利润率 | -181.1% | -13.4% |
| 净利率 | -265.9% | — |
| 营收同比 | 375.0% | 2091.6% |
| 净利润同比 | -51.9% | — |
| 每股收益（稀释后） | $-0.28 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLLSIPM
| Q4 25 | — | $6.1M | ||
| Q3 25 | — | $6.2M | ||
| Q2 25 | — | $5.7M | ||
| Q1 25 | — | $5.5M | ||
| Q2 24 | $9.5M | — | ||
| Q4 23 | — | $-7.3M | ||
| Q3 23 | $1.6M | $2.8M | ||
| Q2 23 | $2.0M | $3.0M |
净利润CLLSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.1M | ||
| Q2 25 | — | $-1.1M | ||
| Q1 25 | — | $808.5K | ||
| Q2 24 | $-25.3M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-17.5M | $-181.6K | ||
| Q2 23 | $-16.6M | $135.6K |
毛利率CLLSIPM
| Q4 25 | — | 53.1% | ||
| Q3 25 | — | 50.7% | ||
| Q2 25 | — | 50.1% | ||
| Q1 25 | — | 55.3% | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 70.1% | ||
| Q2 23 | 97.3% | 73.8% |
营业利润率CLLSIPM
| Q4 25 | — | -13.4% | ||
| Q3 25 | — | -23.0% | ||
| Q2 25 | — | -19.7% | ||
| Q1 25 | — | -24.2% | ||
| Q2 24 | -181.1% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -1258.1% | -14.1% | ||
| Q2 23 | -1180.5% | -9.4% |
净利率CLLSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | -17.4% | ||
| Q2 25 | — | -18.3% | ||
| Q1 25 | — | 14.7% | ||
| Q2 24 | -265.9% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -1064.1% | -6.6% | ||
| Q2 23 | -831.6% | 4.6% |
每股收益（稀释后）CLLSIPM
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-0.08 | ||
| Q1 25 | — | $0.06 | ||
| Q2 24 | $-0.28 | — | ||
| Q4 23 | — | $-0.03 | ||
| Q3 23 | $-0.31 | $-0.02 | ||
| Q2 23 | $-0.20 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $149.0M | $5.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $148.6M | $18.2M |
| 总资产 | $407.1M | $26.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLLSIPM
| Q4 25 | — | $5.6M | ||
| Q3 25 | — | $7.3M | ||
| Q2 25 | — | $7.3M | ||
| Q1 25 | — | $9.7M | ||
| Q2 24 | $149.0M | — | ||
| Q4 23 | — | $13.6M | ||
| Q3 23 | — | $13.7M | ||
| Q2 23 | $84.4M | $13.7M |
股东权益CLLSIPM
| Q4 25 | — | $18.2M | ||
| Q3 25 | — | $18.8M | ||
| Q2 25 | — | $19.9M | ||
| Q1 25 | — | $21.1M | ||
| Q2 24 | $148.6M | — | ||
| Q4 23 | — | $20.1M | ||
| Q3 23 | $76.1M | $20.4M | ||
| Q2 23 | $96.6M | $20.5M |
总资产CLLSIPM
| Q4 25 | — | $26.0M | ||
| Q3 25 | — | $27.2M | ||
| Q2 25 | — | $29.8M | ||
| Q1 25 | — | $31.1M | ||
| Q2 24 | $407.1M | — | ||
| Q4 23 | — | $23.9M | ||
| Q3 23 | $209.7M | $24.1M | ||
| Q2 23 | $227.7M | $24.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $87.6K |
| 自由现金流经营现金流 - 资本支出 | $27.6M | — |
| 自由现金流率自由现金流/营收 | 290.5% | — |
| 资本支出强度资本支出/营收 | 13.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLLSIPM
| Q4 25 | — | $87.6K | ||
| Q3 25 | — | $133.0K | ||
| Q2 25 | — | $-888.7K | ||
| Q1 25 | — | $1.7M | ||
| Q2 24 | $28.9M | — | ||
| Q4 23 | — | $-99.0K | ||
| Q3 23 | — | $16.1K | ||
| Q2 23 | $-47.4M | $-193.8K |
自由现金流CLLSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | $27.6M | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | $-47.9M | — |
自由现金流率CLLSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | 290.5% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | -2391.4% | — |
资本支出强度CLLSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | 13.2% | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | 24.1% | — |
现金转化率CLLSIPM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.16× | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -1.43× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLLS
暂无分部数据
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
